HomeInsightsPE

Advanced Enzyme Technologies Ltd P/E Ratio

Advanced Enzyme Technologies Ltd P/E Ratio

download
stocks purchased

₹ 0.6 Cr

Volume transacted

stocks purchased

16.0 K

stocks traded

Last Updated time: 21 Jul 9.00 AM

Image

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES

PE

28.9

Last updated : 21 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Advanced Enzyme Technologies Ltd is 28.9 as of 21 Jul 9.00 AM .a1#The P/E Ratio of Advanced Enzyme Technologies Ltd changed from 18.4 on March 2019 to 29.1 on March 2024 . This represents a CAGR of 7.94% over 6 years. a1#The Latest Trading Price of Advanced Enzyme Technologies Ltd is ₹ 372.25 as of 19 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.6 in 5 years. This represents a CAGR of -0.64%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 23.8. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 38.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.4. In 2024a1#The Market Cap of Advanced Enzyme Technologies Ltd changed from ₹ 2042 crore on March 2019 to ₹ 3885 crore on March 2024 . This represents a CAGR of 11.32% over 6 years. a1#The Revenue of Advanced Enzyme Technologies Ltd changed from ₹ 123.12 crore to ₹ 167.31 crore over 8 quarters. This represents a CAGR of 16.57% a1#The EBITDA of Advanced Enzyme Technologies Ltd changed from ₹ 32.92 crore to ₹ 49.74 crore over 8 quarters. This represents a CAGR of 22.92% a1#The Net Pr of Advanced Enzyme Technologies Ltd changed from ₹ 17.58 crore to ₹ 29.87 crore over 8 quarters. This represents a CAGR of 30.35% a1#The Dividend Payout of Advanced Enzyme Technologies Ltd changed from 19.02 % on March 2019 to 52.76 % on March 2024 . This represents a CAGR of 18.54% over 6 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Advanced Enzyme Technologies Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Advanced Enzyme Technologies Ltd

Period
Mar '1918.4
Mar '2012.4
Mar '2126.4
Mar '2226.4
Mar '2324.5
Mar '2429.1

Company Fundamentals for Advanced Enzyme Technologies Ltd

Market Cap

4,162 Cr

EPS

12.9

P/E Ratio (TTM) *

28.9

P/B Ratio (TTM) *

3.1

Day’s High

376.6

Day’s Low

371.1

DTE *

0.0

ROE *

10.1

52 Week High

425.1

52 Week Low

292.0

ROCE *

13.9

* All values are consolidated

Last Updated time: 21 Jul 9.00 AM

* All values are consolidated

Last Updated time: 21 Jul 9.00 AM

Image

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES

PRICE

372.25

-5.45 (-1.44%)

stock direction

Last updated : 19 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Advanced Enzyme Technologies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

Asset Value vs Market Value of Advanced Enzyme Technologies Ltd

Market Value

4,163

Asset Value

476

7.7 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Advanced Enzyme Technologies Ltd284,162
Sun Pharmaceuticals Industries Ltd37376,324
Divis Laboratories Ltd74119,994
Cipla Ltd28119,929
Zydus Lifesciences Ltd29115,174
Dr Reddys Laboratories Ltd20110,759

Key Valuation Metric of Advanced Enzyme Technologies Ltd

Earnings

133 Cr

28.9 X

PE Ratio

Market Cap

₹4162Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

133 Cr

28.9 X

PE Ratio

Market Cap

₹4162Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Advanced Enzyme Technologies Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Advanced Enzyme Technologies Ltd

Period
Mar '192042
Mar '201599
Mar '213853
Mar '223154
Mar '232590
Mar '243886

* All values are a in crore

×

Historical Revenue of Advanced Enzyme Technologies Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Advanced Enzyme Technologies Ltd

Period
Jun '22123
Sep '22143
Dec '22151
Mar '23150
Jun '23154
Sep '23164
Dec '23175
Mar '24167

* All values are a in crore

×

Historical EBITDA of Advanced Enzyme Technologies Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Advanced Enzyme Technologies Ltd

Period
Jun '2233
Sep '2244
Dec '2250
Mar '2351
Jun '2351
Sep '2357
Dec '2368
Mar '2450

* All values are a in crore

×

Historical Net Profit of Advanced Enzyme Technologies Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Advanced Enzyme Technologies Ltd

Period
Jun '2218
Sep '2226
Dec '2228
Mar '2332
Jun '2329
Sep '2335
Dec '2343
Mar '2430

* All values are a in crore

×

Historical Dividend Payout of Advanced Enzyme Technologies Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Advanced Enzyme Technologies Ltd

Period
Mar '1919
Mar '2012
Mar '2114
Mar '2221
Mar '2320
Mar '2453

* All values are a in %

About Advanced Enzyme Technologies Ltd

About Advanced Enzyme Technologies Ltd

    Advanced Enzyme Technologies Limited (AETL) is largest Indian enzyme company that has transformed business globally in the manufacturing of enzymes by improving the fundamentals based on research and technology. The Company is engaged in the research and development, manufacturing and marketing of over 400 proprietary products developed from over 68 indigenous enzymes and probiotics. It has manufacturing facilities and research & development centers across India, Germany and the US. Advanced Enzyme Technologies Limited (AETL) was incorporated, as a Private Limited Company on March 15, 1989 under the provisions of the Companies Act, 1956 as 'Advanced Biochemicals Private Limited' in Maharashtra. Pursuant to a Special Resolution passed by the Shareholders of the Company at the Extra-Ordinary General Meeting held on April 21, 1992, the Company was converted into a Public Limited Company and consequently, name of the Company got changed to Advanced Biochemicals Limited. A fresh Certificate of Incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a Special Resolution passed by the Shareholders of the Company at the Extra-Ordinary General Meeting held on August 8, 2005, name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh Certificate of Incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005. In 2011, the company took over Cal-India Foods International, giving the company direct presence in USA. In 2012, the company took over Advanced Supplementary Technologies Corporation for consolidating its presence in USA. Advanced Enzyme Technologies Limited came out with its Initial Public Offer (IPO) of 4,594,875 Equity shares of Rs 10 each at an issue price of Rs 896 per Equity share ( Rs 810 per Equity share for eligible employees), consisting of fresh issue of 560,405 Equity shares and an Offer for Sale of 4,034,470 Equity shares by Selling Shareholders. The IPO was open for subscription during the period from 20 July2016 to 22 July 2016. The said offer was overall subscribed 82.06 times. The equity shares of Advanced Enzyme Technologies Limited were listed on National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on 1 August 2016 at an opening market price of Rs 1,210 on both the exchanges compared with the IPO price of Rs 896 per share. During the financial year ended 31 March 2017, Advanced Enzyme Technologies Limited acquired 1.43 crore equity shares at Rs 35 per share of JC Biotech Private Limited (JCB), aggregating to Rs 50.08 crore, 70% of the paid-up share capital of JCB. In view of this JCB became subsidiary with effect from December 1, 2016. The sub-division of equity shares of the company from face value of 10 each to face value of 2 each (Stock Split) and consequent alteration in Capital Clause of Memorandum of Association of was approved by the company's shareholders on May 04, 2017, through a Postal Ballot. The Record Date' for the purpose of ascertaining the shareholders entitled to receive the said sub-divided equity shares was fixed by the Board as May 26, 2017. Subsequently, the company issued five (5) sub-divided equity shares of 2 each in lieu of one (1) equity share of 10 each to the eligible shareholders of the company. On 3 July 2017, Advanced Enzyme Technologies completed the acquisition of 200,000 equity shares of MYR 1 (Malaysia Ringgit) each aggregating to MYR 200,000 (equivalent to approx. 3,134,000) of AEM i.e. 80% of paid-up share capital of AEM. The company also subscribed to right issue of 150,000 Equity Shares at MYR 1 per share of AEM, aggregating to MYR 150,000 (equivalent to 2,602,500) on 13 March 2018. On 20 March 2018, the company completed the acquisition of remaining stake i.e. 50,000 equity shares of face value of MYR 1 each of AEM. The said acquisition was made at face value for a total consideration of MYR 50,000 (equivalent to 867,800). In view of the above, AEM has become a wholly-owned subsidiary of the company, effective from March 30, 2018. Advanced Enzyme Technologies incorporated a wholly owned subsidiary Advanced Enzymes Europe BV (AEE) with issued share capital of Euro 2 Million [2,000,000 equity shares of EUR 1 each] (equivalent to approx. Rs 149.84 Million) in Netherlands on July 11, 2017 mainly to expand your company's business in European Market. The company's wholly owned subsidiary, Advanced Enzymes Europe BV completed the acquisition of 100% stake in evoxx technologies GmbH (evoxx) for a consideration of ? 6.57 million, on August 15, 2017. In view of above, evoxx become a step-down subsidiary (100%) of the company. On 3 October 2017, the company's subsidiary Advanced Supplementary Technologies Corporation (ASTC) acquired certain assets and liabilities of Biomedic Labs, LLC, USA for a purchase consideration of USD 750,000. The company has accounted for goodwill of USD 630,000 equivalent to Rs. 40.98 Million on consolidation. During the financial year ended 31 March 2018, Advanced Enzyme Technologies subscribed to right issue of 189,000 equity shares of 10 each at a premium of 27 per equity share aggregating to 6,993,000 of JC Biotech Private Limited (JCB). The shares have been duly allotted on January 31, 2018. The purpose of Right Issue was mainly to meet the capital & operational expenditure of JCB. As the Right Issue was offered & subscribed by JCB's existing shareholders in proportionate to their respective shareholding in JCB, the shareholding of Advanced Enzyme Technologies in JCB remains same i.e. 70%. As on March 31, 2019, the Company had 11 subsidiaries. As on March 31, 2020, the Company had 11 subsidiaries. As on March 31, 2021 the Company had 12 subsidiaries. In January 2021, it completed the acquisition of controlling stake of 51% in SciTech Specialities Private Limited (SSPL), India, a contract manufacturing company specializing in effervescent granules and tablets with 2 manufacturing facilities and 1 R&D unit, which became a subsidiary of Company effective from January 11, 2021. On 29 May 2021, Company acquired additional stake of 15% from existing shareholders of JC Biotech Private Limited (JCB) at a consideration of Rs. 211.25 Million.

Advanced Enzyme Technologies Ltd News Hub

News

Advanced Enzyme Techs. schedules AGM

Advanced Enzyme Techs. announced that the 35th Annual General Meeting (AGM) of the company...

Read more

26 Jun 202413:49

News

Board of Advanced Enzyme Techs. recommends Final Dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting...

Read more

11 May 202413:43

News

Board of Advanced Enzyme Techs. recommends Interim Dividend

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting...

Read more

11 May 202413:51

News

Advanced Enzyme Techs. to hold board meeting

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 11 ...

Read more

07 May 202412:58

News

Advanced Enzyme Tech gains after Q3 PAT rises 52% YoY

On the segmental front, the revenue from human nutrition segment increased by 19% to Rs 11...

Read more

12 Feb 202410:39

News

Advanced Enzyme Techs. announces board meeting date

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

03 Feb 202420:05

Product Composition by Percentage (Revenue)

FAQs for PE of Advanced Enzyme Technologies Ltd

What is Advanced Enzyme Technologies Ltd current share price?

The current market price of Advanced Enzyme Technologies Ltd as of July 21, 2024 is ₹372.25.

What is Advanced Enzyme Technologies Ltd's market cap?

Advanced Enzyme Technologies Ltd's market capitalisation stood at ₹4,162 Cr as of July 21, 2024

What are Advanced Enzyme Technologies Ltd's total net assets?

According to Advanced Enzyme Technologies Ltd's most recent financial filings, the company's net assets total ₹476.4 Cr.

Is Advanced Enzyme Technologies Ltd making a profit or loss?

Advanced Enzyme Technologies Ltd's net Profit as of July 21, 2024 is close to ₹133 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199